From iPSC Starting Material to Scalable GMP Manufacturing

Consistent, scalable iPSC starting material can play a critical role in moving cell therapy programs from early development toward clinical manufacturing. Yet building a reliable supply of high-quality cells introduces challenges around working cell banks, expansion media, process reproducibility, and scale that can add time and complexity to development.

This on-demand webinar explores an integrated approach to iPSC expansion designed to create a more consistent foundation for downstream cell therapy development. See how established GMP iPSC lines, standardized working cell banks, GMP-compatible expansion media, and defined processes can work together to support reproducible, high-volume cell production.

The discussion also examines key considerations for scaling iPSC expansion to billions of cells while maintaining the consistency needed for downstream differentiation. Whether you are establishing an iPSC feed stream or preparing an existing process for future cGMP manufacturing, this webinar offers practical insight into reducing process-development complexity and creating a clearer path from product development to clinical production.

Watch the webinar to explore a more streamlined approach to scalable iPSC manufacturing.